Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests High-Tech glucose monitors for pregnant women with diabetes

NCT ID NCT05370612

Knowledge-focused Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether using a continuous glucose monitor (CGM) is better than standard finger-prick checks for managing blood sugar in pregnant women with type 2 diabetes. Sixteen women participated, and researchers measured how well blood sugar stayed in a healthy range and how satisfied the women were with their diabetes care. The goal was to see if CGM is practical and helpful for this group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

16 people

The number who actually took part.

Started

Aug 2022

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age greater than or equal to 18 years of age at enrollment * Ability to consent in English * Gestational age less than or equal to 19 weeks 6 days at enrollment * Appropriate dating by certain LMP or ultrasound performed less than or equal to 19 weeks 6 day * Diagnosis of Type 2 Diabetes less than or equal to 19 weeks 6 days * Singleton gestation Exclusion Criteria: * Age less than 18 years of age at enrollment * Lack of appropriate dating * Multiple gestations * Use of concentrated insulin at enrollment (ie U500) * Preexisting CGM in place * Chronic use of medications known to cause hyperglycemia, such as HIV antiretrovirals and inhaled, injectable and oral corticosteroids * Be unwilling or unable to present to Center for Perinatal Care for visits

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy in diabetic are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes Pregnancy in Diabetics type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pregnancy in diabetic TYPE2DIABETES

Contacts and locations

Locations

  • University of Wisconsin

    Madison, Wisconsin, 53715, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.